GZMB and systemic lupus erythematosus: Grassi et al. demonstrated that the expression of Granzyme B + cells was more frequent in skin biopsies from SLE + patients, compared to patients with purely CLE, suggesting that Granzyme B is a key cytotoxicity marker in SLE + individuals.15